ETF Preview: ETFs, Stocks Slip Lower Ahead of Consumer Confidence, House Price Data; Syria Worries Weigh

By Staff,

Shutterstock photo

Active broad-market exchange-traded funds in Monday's regular session:

SPDR S&P 500 ( SPY ): -0.42%

iShares S&P 500 ( IVV ): -0.38%

PowerShares QQQ ( QQQ ): +0.05%

iShares Russell 2000 ( IWM ): +0.02%

iShares Russell 1000 Growth ( IWF ): -0.10%

iShares MSCI Emerging Markets Index (EEM): -1.09%

United States Oil Fund (USO): +0.03%

SPDR Gold Shares (GLD): +0.41%

Select Financial Sector SPDRS (XLF): -0.65%

Pre-Market Most Active:

SPY, -0.66%

EEM, -1.12%

VXX, +2.94%

EWJ, +0.45%

GDX, +1.64%

Broad Market Indicators

Broad-market exchange-traded funds, including SPY, IWM, IVV and others, are weaker. Actively traded PowerShares QQQ ( QQQ ) is down 0.87%.

U.S. stock futures are edging lower as concerns over military action against Syria by the U.S. start to grow following U.S. Secretary of State John Kerry's statement that the Syrian government had indeed used chemical weapons. The tensions between the U.S. and Syria have driven oil prices higher. Upcoming economic data may provide more direction for the market: the S&P/Case-Shiller 20-city composite index will release data at 9 am ET, while the Conference Board will report consumer-confidence data at 10 am ET.

Winners and Losers

Financial -

Select Financial Sector SPDRs (XLF) is up 0.81%. Direxion Daily Financial Bull 3X shares (FAS) is up 2.52%. Its bearish counterpart, FAZ, is down 2.55%.

Among financial stocks, Bank of Nova Scotia (BNS) reported Q3 diluted EPS of CAD 1.37 or $1.30, down from CAD 1.69 or $1.61 in the same period a year ago. Analysts polled by Capital IQ were expecting CAD 1.29 or $1.23 EPS. Revenues were CAD 5.6 billion or $5.32 billion, versus the estimates of CAD 5.3 billion or $5.04 billion.

Technology -

Tech ETFs Technology Select Sector SPDR ETF (XLK), iShares Dow Jones US Technology ETF (IYW), iShares S&P North American Technology ETF (IGM) and iShares S&P North American Technology-Software Index (IGV) are leaning higher.

Semiconductor ETFs, SPDR S&P Semiconductor (XSD) and Semiconductor Sector Index Fund (SOXX) look to open in the green.

SPDR S&P International Technology Sector ETF (IPK) is headed for a flat to higher open.

In sector news, Google (GOOG) is off 0.33% following several media reports that the tech giant is under investigation by the U.K's Office of Fair Trade for its acquisition of Waze, an Israeli mobile traffic app provider.

Energy -

Dow Jones U.S. Energy Fund (IYE) and Energy Select Sector SPDR (XLE) are heading for a firmer start.

In sector news, PetroChina (PTR) is down 4.06% after three executives under investigation resigned. The company was planning management change at its Daqing oilfield after a government probe of the unit's top executive, said two people familiar with the situation, according to Bloomberg.

Commodities -

October crude is up 1.70%; November natural gas is down 1.39%. United States Oil Fund (USO) is up 2.05%. United States Natural Gas Fund (UNG) is down 0.22%.

Gold and silver for December delivery are both hgiher, up 1.47% and 1.41%, respectively. Among rare metal funds, SPDR Gold Trust (GLD) is up 1.11%; iShares Silver Trust (SLV) is up 0.30%.

Consumer -

Consumer ETFs Consumer Staples Select Sector SPDR (XLP), iShares Dow Jones US Consumer Goods (IYK), and Vanguard Consumer Staples ETF (VDC) are pointing to a higher start.

In sector news, mira Nature Foods Ltd. (ANFI) is up 9.76% after the Indian specialty rice maker posted late Monday Q1 EPS of $0.21, easily beating Capital IQ estimates of $0.11. Revenue increased 37.6% to $110.3 million, also better than CIQ estimates of $98.8 million. For FY14, ANFI sees revenue in the range of $480 million to $507 million, straddling CIQ estimates of $498.7 million.

Healthcare -

Healthcare ETFs Health Care SPDR (XLV), Vanguard Health Care ETF (VHT), and iShares Dow Jones US Healthcare (IYH) are pointing to a negative start. Biotech ETF iShares NASDAQ Biotechnology Index (IBB) is also pointing lower.

In corporate news, Acura Pharmaceuticals (ACUR) is down 18.72% after it reported late Monday top-line results of a clinical study assessing abuse liability of snorting a crushed hydrocodone bitartrate with acetaminophen tablet formulated with Acura's abuse deterrent AVERSION technology. The trial's results for the primary endpoint were not statistically significant.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing Commodities
Referenced Stocks: IVV , IWF , IWM , QQQ , SPY

More from MT Newswires


MT Newswires

MT Newswires

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by